Qube Research & Technologies Ltd - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$330,085
+19.3%
60,566
+46.8%
0.00%0.0%
Q2 2023$276,794
-50.8%
41,251
-35.3%
0.00%
-50.0%
Q1 2023$562,877
-8.3%
63,746
-26.1%
0.00%
-50.0%
Q3 2022$614,000
+19.9%
86,280
+36.2%
0.00%0.0%
Q2 2022$512,000
-31.3%
63,340
+18.0%
0.00%
-33.3%
Q1 2022$745,000
-15.1%
53,671
+146.5%
0.01%
-57.1%
Q1 2021$877,00021,7770.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders